Wegovy 0.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FN4ME
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,358
Award facts
- Contract value 100% obligated
- $10,357.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,357.81 by the Defense Logistics Agency on September 18, 2025, for the supply of Wegovy (semaglutide) 0.5 mg/0.5 mL pen injections. The contract is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
The Defense Logistics Agency, which operates under the Department of Defense, procures medical supplies and pharmaceuticals to support military and veteran healthcare systems. This delivery order reflects the agency's procurement of specialty medications through established vendor relationships, with AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through open competition. The company's extensive federal contract portfolio and principal IDC vehicle position it as a critical supplier of both brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains for the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FN4ME?
SPE2DB25FN4ME was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FN4ME worth?
The government has obligated $10,358 on SPE2DB25FN4ME.
Is contract SPE2DB25FN4ME an order under another contract?
Yes. SPE2DB25FN4ME is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN4ME competed?
The extent of competition for SPE2DB25FN4ME was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award